Header Logo

Connection

ANAIS MALPICA to Aged

Back to Details
This is a "connection" page, showing publications ANAIS MALPICA has written about Aged.
ANAIS MALPICA
Connection Strength
0.747
Aged
  1. Extrauterine Mesonephric-like Carcinoma: A Comprehensive Single Institution Study of 33 Cases. Am J Surg Pathol. 2023 06 01; 47(6):635-648.
    View in: PubMed
    Score: 0.036
  2. Localized Malignant Peritoneal Mesothelioma (LMPeM) in Women: A Clinicopathologic Study of 18 Cases. Am J Surg Pathol. 2022 10 01; 46(10):1352-1363.
    View in: PubMed
    Score: 0.034
  3. Malignant Peritoneal Mesothelioma Associated With Endometriosis: A Clinicopathologic Study of 15 Cases. Int J Gynecol Pathol. 2022 Jan 01; 41(1):59-67.
    View in: PubMed
    Score: 0.033
  4. TP53 variant allele frequency correlates with the chemotherapy response score in ovarian/fallopian tube/peritoneal high-grade serous carcinoma. Hum Pathol. 2021 09; 115:76-83.
    View in: PubMed
    Score: 0.031
  5. Malignant Mesothelioma of the Peritoneum in Women: A Clinicopathologic Study of 164 Cases. Am J Surg Pathol. 2021 01; 45(1):45-58.
    View in: PubMed
    Score: 0.030
  6. Prophylactic Risk-reducing Hysterectomies and Bilateral Salpingo-oophorectomies in Patients With Lynch Syndrome: A Clinicopathologic Study of 29 Cases and Review of the Literature. Int J Gynecol Pathol. 2020 Jul; 39(4):313-320.
    View in: PubMed
    Score: 0.029
  7. Mesonephric-like Carcinoma of the Endometrium: A Subset of Endometrial Carcinoma With an Aggressive Behavior. Am J Surg Pathol. 2020 04; 44(4):429-443.
    View in: PubMed
    Score: 0.029
  8. A 3-Tier Chemotherapy Response Score for Ovarian/Fallopian Tube/Peritoneal High-grade Serous Carcinoma: Is it Clinically Relevant? Am J Surg Pathol. 2020 02; 44(2):206-213.
    View in: PubMed
    Score: 0.028
  9. Ultrastaging of Sentinel Lymph Nodes in Endometrial Carcinoma According to Use of 2 Different Methods. Int J Gynecol Pathol. 2018 May; 37(3):242-251.
    View in: PubMed
    Score: 0.025
  10. Neuroendocrine Carcinoma of the Endometrium: A Clinicopathologic Study of 25 Cases. Am J Surg Pathol. 2016 May; 40(5):577-86.
    View in: PubMed
    Score: 0.022
  11. Endometrioid stromal sarcoma: a clinicopathologic study of 63 cases. Am J Surg Pathol. 2013 Nov; 37(11):1635-47.
    View in: PubMed
    Score: 0.018
  12. Low-grade smooth muscle tumors of the primary and the secondary mullerian system: a proposed concept of multicentricity. Int J Gynecol Pathol. 2012 Nov; 31(6):547-55.
    View in: PubMed
    Score: 0.017
  13. Ovarian serous tumors of low malignant potential with nodal low-grade serous carcinoma. Am J Surg Pathol. 2012 Jul; 36(7):955-63.
    View in: PubMed
    Score: 0.017
  14. Well-differentiated papillary mesothelioma of the female peritoneum: a clinicopathologic study of 26 cases. Am J Surg Pathol. 2012 Jan; 36(1):117-27.
    View in: PubMed
    Score: 0.016
  15. Dermatofibrosarcoma protuberans of the vulva: a clinicopathologic and immunohistochemical study of 13 cases. Am J Surg Pathol. 2010 Mar; 34(3):393-400.
    View in: PubMed
    Score: 0.014
  16. Ovarian intestinal type mucinous borderline tumors: are we ready for a nomenclature change? Int J Gynecol Pathol. 2010 Mar; 29(2):108-12.
    View in: PubMed
    Score: 0.014
  17. Lymph node involvement in ovarian serous tumors of low malignant potential: a clinicopathologic study of thirty-six cases. Am J Surg Pathol. 2010 Jan; 34(1):1-9.
    View in: PubMed
    Score: 0.014
  18. Uterine smooth muscle tumor of uncertain malignant potential: a retrospective analysis. Gynecol Oncol. 2009 Jun; 113(3):324-6.
    View in: PubMed
    Score: 0.013
  19. Uterine tumors with neuroectodermal differentiation: a series of 17 cases and review of the literature. Am J Surg Pathol. 2008 Feb; 32(2):219-28.
    View in: PubMed
    Score: 0.012
  20. Metastatic colorectal adenocarcinoma involving the ovary with elevated serum CA125: a potential diagnostic pitfall. Gynecol Oncol. 2007 May; 105(2):395-8.
    View in: PubMed
    Score: 0.012
  21. Endometrioid carcinoma simultaneously involving the uterus and the fallopian tube: a clinicopathologic study of 13 cases. Am J Surg Pathol. 2006 Jul; 30(7):844-9.
    View in: PubMed
    Score: 0.011
  22. Ovarian involvement by metastatic colorectal adenocarcinoma: still a diagnostic challenge. Am J Surg Pathol. 2006 Feb; 30(2):177-84.
    View in: PubMed
    Score: 0.011
  23. Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma? Int J Gynecol Pathol. 2006 Jan; 25(1):52-8.
    View in: PubMed
    Score: 0.011
  24. Serous carcinoma of the ovary and peritoneum with metastases to the breast and axillary lymph nodes: a potential pitfall. Am J Surg Pathol. 2004 Dec; 28(12):1646-51.
    View in: PubMed
    Score: 0.010
  25. Serous carcinoma of the ovary, fallopian tube, or peritoneum presenting as lymphadenopathy. Am J Surg Pathol. 2004 Sep; 28(9):1217-23.
    View in: PubMed
    Score: 0.010
  26. Grading ovarian serous carcinoma using a two-tier system. Am J Surg Pathol. 2004 Apr; 28(4):496-504.
    View in: PubMed
    Score: 0.010
  27. Uterine epithelioid leiomyosarcomas with clear cells: reactivity with HMB-45 and the concept of PEComa. Am J Surg Pathol. 2004 Feb; 28(2):244-9.
    View in: PubMed
    Score: 0.009
  28. Metastatic tumors of the vulva: a clinicopathologic study of 66 cases. Am J Surg Pathol. 2003 Jun; 27(6):799-804.
    View in: PubMed
    Score: 0.009
  29. Metastatic melanoma to the vagina: clinicopathologic and immunohistochemical study of three cases and literature review. Int J Gynecol Pathol. 2003 Apr; 22(2):136-40.
    View in: PubMed
    Score: 0.009
  30. High-grade Neuroendocrine Carcinomas of the Vulva: A Clinicopathologic Study of 16 Cases. Am J Surg Pathol. 2021 03 01; 45(3):304-316.
    View in: PubMed
    Score: 0.008
  31. Hormonal Maintenance Therapy for Women With Low-Grade Serous Cancer of the Ovary or Peritoneum. J Clin Oncol. 2017 Apr 01; 35(10):1103-1111.
    View in: PubMed
    Score: 0.006
  32. Yolk Sac Tumor in Extragonadal Pelvic Sites: Still a Diagnostic Challenge. Am J Surg Pathol. 2017 01; 41(1):1-11.
    View in: PubMed
    Score: 0.006
  33. Tumor Thickness and Mitotic Rate Robustly Predict Melanoma-Specific Survival in Patients with Primary Vulvar Melanoma: A Retrospective Review of 100 Cases. Clin Cancer Res. 2017 04 15; 23(8):2093-2104.
    View in: PubMed
    Score: 0.006
  34. Ovarian Low-grade Serous Carcinoma: A Clinicopathologic Study of 33 Cases With Primary Surgery Performed at a Single Institution. Am J Surg Pathol. 2016 May; 40(5):627-35.
    View in: PubMed
    Score: 0.005
  35. Vascular invasion in uterine sarcomas and its significance. A multi-institutional study. Hum Pathol. 2015 Nov; 46(11):1712-21.
    View in: PubMed
    Score: 0.005
  36. Impact of Age and Primary Disease Site on Outcome in Women With Low-Grade Serous Carcinoma of the Ovary or Peritoneum: Results of a Large Single-Institution Registry of a Rare Tumor. J Clin Oncol. 2015 Aug 20; 33(24):2675-82.
    View in: PubMed
    Score: 0.005
  37. Low-stage clear-cell carcinoma of the endometrium. Am J Surg Pathol. 1995 Jul; 19(7):769-74.
    View in: PubMed
    Score: 0.005
  38. Risk factor analysis of recurrence in low-grade endometrial adenocarcinoma. Hum Pathol. 2015 Oct; 46(10):1529-39.
    View in: PubMed
    Score: 0.005
  39. The role of secondary cytoreduction in low-grade serous ovarian cancer or peritoneal cancer. Gynecol Oncol. 2015 Jan; 136(1):25-9.
    View in: PubMed
    Score: 0.005
  40. Risk factors for recurrence and prognosis of low-grade endometrial adenocarcinoma; vaginal versus other sites. Int J Gynecol Pathol. 2014 May; 33(3):268-73.
    View in: PubMed
    Score: 0.005
  41. Nephrogenic adenoma of the prostatic urethra involving the prostate gland: a clinicopathologic and immunohistochemical study of eight cases. Hum Pathol. 1994 Apr; 25(4):390-5.
    View in: PubMed
    Score: 0.005
  42. KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma. J Pathol. 2013 Dec; 231(4):449-56.
    View in: PubMed
    Score: 0.005
  43. The pattern of myometrial invasion as a predictor of lymph node metastasis or extrauterine disease in low-grade endometrial carcinoma. Am J Surg Pathol. 2013 Nov; 37(11):1728-36.
    View in: PubMed
    Score: 0.005
  44. Prognostic value of the diagnostic criteria distinguishing endometrial stromal sarcoma, low grade from undifferentiated endometrial sarcoma, 2 entities within the invasive endometrial stromal neoplasia family. Int J Gynecol Pathol. 2013 May; 32(3):299-306.
    View in: PubMed
    Score: 0.004
  45. Prognostic comparison of the proliferation markers (mitotic activity index, phosphohistone H3, Ki67), steroid receptors, HER2, high molecular weight cytokeratins and classical prognostic factors in T1?2N0M0 breast cancer. Pol J Pathol. 2013 Apr; 64(1):1-8.
    View in: PubMed
    Score: 0.004
  46. Comparison of the effect of different techniques for measurement of Ki67 proliferation on reproducibility and prognosis prediction accuracy in breast cancer. Histopathology. 2012 Dec; 61(6):1134-44.
    View in: PubMed
    Score: 0.004
  47. Peritoneal washing cytologic analysis of ovarian serous tumors of low malignant potential to detect peritoneal implants and predict clinical outcome. Cancer Cytopathol. 2012 Aug 25; 120(4):238-44.
    View in: PubMed
    Score: 0.004
  48. The 2 stromal compartments of the normal cervix with distinct immunophenotypic and histomorphologic features. Ann Diagn Pathol. 2012 Oct; 16(5):315-22.
    View in: PubMed
    Score: 0.004
  49. Hormonal therapy for recurrent low-grade serous carcinoma of the ovary or peritoneum. Gynecol Oncol. 2012 Jun; 125(3):661-6.
    View in: PubMed
    Score: 0.004
  50. Reclassification of serous ovarian carcinoma by a 2-tier system: a Gynecologic Oncology Group Study. Cancer. 2012 Jun 15; 118(12):3087-94.
    View in: PubMed
    Score: 0.004
  51. Comparison of different commercial methods for HPV detection in follow-up cytology after ASCUS/LSIL, prediction of CIN2-3 in follow up biopsies and spontaneous regression of CIN2-3. Gynecol Oncol. 2011 Nov; 123(2):278-83.
    View in: PubMed
    Score: 0.004
  52. Biomarkers and microsatellite instability analysis of curettings can predict the behavior of FIGO stage I endometrial endometrioid adenocarcinoma. Mod Pathol. 2011 Sep; 24(9):1262-71.
    View in: PubMed
    Score: 0.004
  53. Low-grade serous primary peritoneal carcinoma. Gynecol Oncol. 2011 Jun 01; 121(3):482-6.
    View in: PubMed
    Score: 0.004
  54. Malignant melanoma arising in an ovarian carcinosarcoma: case report and review of the literature. Int J Gynecol Pathol. 2011 Mar; 30(2):158-62.
    View in: PubMed
    Score: 0.004
  55. Molecular biomarkers in endometrial hyperplasias predict cancer progression. Am J Obstet Gynecol. 2011 Apr; 204(4):357.e1-12.
    View in: PubMed
    Score: 0.004
  56. Expression of the retinoblastoma-related gene Rb2/p130 in the pathogenesis of serous carcinoma of the ovary. Appl Immunohistochem Mol Morphol. 2010 Dec; 18(6):509-11.
    View in: PubMed
    Score: 0.004
  57. High frequency microsatellite instability has a prognostic value in endometrial endometrioid adenocarcinoma, but only in FIGO stage 1 cases. Anal Cell Pathol (Amst). 2010; 33(5):245-55.
    View in: PubMed
    Score: 0.004
  58. Polypoid or non-polypoid? A novel dichotomous approach to uterine carcinosarcoma. Gynecol Oncol. 2009 Oct; 115(1):32-36.
    View in: PubMed
    Score: 0.003
  59. The significance of neuroendocrine expression in undifferentiated carcinoma of the endometrium. Int J Gynecol Pathol. 2009 Mar; 28(2):142-7.
    View in: PubMed
    Score: 0.003
  60. Vascular pseudoinvasion in laparoscopic hysterectomy specimens for endometrial carcinoma: a grossing artifact? Am J Surg Pathol. 2009 Feb; 33(2):298-303.
    View in: PubMed
    Score: 0.003
  61. Sinonasal teratocarcinosarcoma of the head and neck: a report of 10 patients treated at a single institution and comparison with reported series. Arch Otolaryngol Head Neck Surg. 2008 Jun; 134(6):592-5.
    View in: PubMed
    Score: 0.003
  62. Automated image analysis of digital colposcopy for the detection of cervical neoplasia. J Biomed Opt. 2008 Jan-Feb; 13(1):014029.
    View in: PubMed
    Score: 0.003
  63. Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum. Gynecol Oncol. 2008 Mar; 108(3):510-4.
    View in: PubMed
    Score: 0.003
  64. Comparison of the clinical behavior of newly diagnosed stages II-IV low-grade serous carcinoma of the ovary with that of serous ovarian tumors of low malignant potential that recur as low-grade serous carcinoma. Gynecol Oncol. 2007 Jun; 105(3):625-9.
    View in: PubMed
    Score: 0.003
  65. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent. Am J Surg Pathol. 2006 Nov; 30(11):1367-71.
    View in: PubMed
    Score: 0.003
  66. Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary. Obstet Gynecol. 2006 Aug; 108(2):361-8.
    View in: PubMed
    Score: 0.003
  67. Cyclin E expression is correlated with tumor progression and predicts a poor prognosis in patients with ovarian carcinoma. Cancer. 2006 May 01; 106(9):1925-32.
    View in: PubMed
    Score: 0.003
  68. Discordant genetic changes in ovarian and endometrial endometrioid carcinomas: a potential pitfall in molecular diagnosis. Int J Gynecol Cancer. 2006 Jan-Feb; 16(1):178-82.
    View in: PubMed
    Score: 0.003
  69. Results of a pilot study of multispectral digital colposcopy for the in vivo detection of cervical intraepithelial neoplasia. Gynecol Oncol. 2005 Dec; 99(3 Suppl 1):S67-75.
    View in: PubMed
    Score: 0.003
  70. Undifferentiated carcinoma of the endometrium. Am J Surg Pathol. 2005 Oct; 29(10):1316-21.
    View in: PubMed
    Score: 0.003
  71. Subvisual chromatin changes in cervical epithelium measured by texture image analysis and correlated with HPV. Gynecol Oncol. 2005 Dec; 99(3 Suppl 1):S16-23.
    View in: PubMed
    Score: 0.003
  72. Results of a phase II double-blinded randomized clinical trial of difluoromethylornithine for cervical intraepithelial neoplasia grades 2 to 3. Clin Cancer Res. 2005 Jan 01; 11(1):390-6.
    View in: PubMed
    Score: 0.003
  73. Skene's gland adenocarcinoma resembling prostatic adenocarcinoma. Int J Gynecol Pathol. 2004 Jan; 23(1):71-4.
    View in: PubMed
    Score: 0.002
  74. Characteristics of recurrence in patients who underwent lymphatic mapping for vulvar cancer. Gynecol Oncol. 2004 Jan; 92(1):205-10.
    View in: PubMed
    Score: 0.002
  75. Groin recurrence in patients with vulvar cancer with negative nodes on superficial inguinal lymphadenectomy. Gynecol Oncol. 2003 Sep; 90(3):625-8.
    View in: PubMed
    Score: 0.002
  76. Relationship between collagen autofluorescence of the human cervix and menopausal status. Photochem Photobiol. 2003 Jun; 77(6):653-8.
    View in: PubMed
    Score: 0.002
  77. Benign cystic mesothelioma of the peritoneum: a clinicopathologic study of 17 cases and immunohistochemical analysis of estrogen and progesterone receptor status. Hum Pathol. 2003 Apr; 34(4):369-74.
    View in: PubMed
    Score: 0.002
  78. beta-catenin nuclear localization is associated with grade in ovarian serous carcinoma. Gynecol Oncol. 2003 Mar; 88(3):363-8.
    View in: PubMed
    Score: 0.002
  79. Cisplatin and irinotecan (CPT-11) for peritoneal mesothelioma. Cancer Invest. 2003; 21(5):682-9.
    View in: PubMed
    Score: 0.002
  80. Vaginal melanoma: a clinicopathologic and immunohistochemical study of 26 cases. Am J Surg Pathol. 2002 Nov; 26(11):1450-7.
    View in: PubMed
    Score: 0.002
  81. Micropapillary and cribriform patterns in ovarian serous tumors of low malignant potential: a study of 99 advanced stage cases. Am J Surg Pathol. 2002 Sep; 26(9):1129-41.
    View in: PubMed
    Score: 0.002
  82. Wolffian duct tumors: case reports and review of the literature. Gynecol Oncol. 2002 Aug; 86(2):225-30.
    View in: PubMed
    Score: 0.002
  83. Vessels within vessels in the myometrium. Am J Surg Pathol. 2002 Feb; 26(2):232-6.
    View in: PubMed
    Score: 0.002
  84. The association of benign and malignant ovarian adenofibromas with breast cancer and thyroid disorders. Int J Surg Pathol. 2002 Jan; 10(1):33-9.
    View in: PubMed
    Score: 0.002
  85. Ovarian mixed-epithelial carcinomas with a microcystic pattern and signet-ring cells. Int J Gynecol Pathol. 2001 Oct; 20(4):323-8.
    View in: PubMed
    Score: 0.002
  86. Non-Hodgkin's lymphoma involving the vulva. Int J Gynecol Pathol. 2000 Jul; 19(3):236-42.
    View in: PubMed
    Score: 0.002
  87. Dermatofibrosarcoma protuberans of the vulva: clinicopathologic and immunohistochemical analysis of four cases, one with fibrosarcomatous change, and review of the literature. Int J Gynecol Pathol. 1999 Oct; 18(4):366-73.
    View in: PubMed
    Score: 0.002
  88. Ovarian serous neoplasms of low malignant potential associated with focal areas of serous carcinoma. Mod Pathol. 1997 Jul; 10(7):663-7.
    View in: PubMed
    Score: 0.001
  89. Risk of urethral, vaginal and cervical involvement in patients undergoing radical cystectomy for bladder cancer: results of a contemporary cystectomy series from M. D. Anderson Cancer Center. J Urol. 1997 Jun; 157(6):2120-3.
    View in: PubMed
    Score: 0.001
  90. Potential applications of intraoperative lymphatic mapping in vulvar cancer. Gynecol Oncol. 1995 Nov; 59(2):216-20.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.